Trade and other receivables

12 Months Ended

Jun. 30, 2025

Trade And Other Receivables

Trade and other receivables

12. Trade and other receivables

	2025			2025			2024
	US$			S$			S$
Trade receivables:
- third parties		2,580,313			3,281,902			2,133,573
Less: Allowance for expected credit loss		(781,133	)		(993,524	)		(460,413	)
		1,799,180			2,288,378			1,673,160
Deposits		5,362,632			6,820,731			90,252
Prepayments		326,983			415,890			28,163
Other receivables:
- third parties		162,070			206,391			213,644
		7,651,065			9,731,390			2,005,219

Trade receivables are unsecured, non-interest bearing and are generally on 60 days terms (June 30, 2024: 60 days).

There is no other class of financial assets that is past due and/or impaired except for trade receivables.

Trade and other receivables are denominated in Singapore Dollar.

The deposits include payments made for custodian services amounting to S$2,300,375 (US$1,683,776), which are classified as non-financial assets and earmarked for use in upcoming mergers and acquisitions within the Singapore market.

Basel Medical Group Ltd. and its Subsidiaries

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For year ended June 30, 2025 and 2024

12. Trade and other receivables (Continued)

The movement in allowance for expected credit losses of trade receivables computed based on lifetime ECL was as follows:

	2025			2025			2024
	US$			S$			S$
Beginning of financial year		361,988			460,413			465,986
Allowance for expected credit losses		536,403			682,252			50,168
Less: Reversal of allowance for expected credit losses		(117,258	)		(149,141	)		(55,741	)
End of financial year		781,133			993,524			460,413